Showing results (591-600 of 995) with videos related to
Sort By:
Pageof 100
Sleep Medicine|May 15, 2013
Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in GermanyKarin Stiasny-Kolster, Daniela Berg, Werner E Hofmann, et al.Plos One|March 29, 2014
Mild parkinsonian signs in the elderly--is there an association with PD? Crossectional findings in 992 individualsStefanie Lerche, Markus Hobert, Kathrin Brockmann, et al.Der Nervenarzt|December 14, 2023
[Dementia with Lewy bodies: old and new knowledge-Part 2: treatment]Richard Dodel, Daniela Berg, Thomas Duning, et al.Der Nervenarzt|December 13, 2023
[Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics]Richard Dodel, Daniela Berg, Thomas Duning, et al.Frontiers in Aging Neuroscience|November 12, 2014
Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controlsSandra E Hasmann, Daniela Berg, Markus A Hobert, et al.Parkinsonism & Related Disorders|December 17, 2014
Reasons for mild parkinsonian signs - which constellation may indicate neurodegeneration?Stefanie Lerche, Kathrin Brockmann, Isabel Wurster, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2021
Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian SyndromesCheng Jiang, Franziska Hopfner, Daniela Berg, et al.Journal of Cellular Physiology|March 11, 2011
Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPARDaniela Berg, Claudia Wolff, Katharina Malinowsky, et al.NPJ Parkinson'S Disease|May 9, 2025
The prodromal individuals' perspective on active recruitment for early detection of α-synucleinopathiesSinah Röttgen, Eva Schaeffer, Annette Rogge, et al.Journal of Alzheimer'S Disease : JAD|December 5, 2012
Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patientsChristoph Laske, Michael Schmohl, Thomas Leyhe, et al.Pageof 100